Independent US pharmacies close at an alarming rate due to PBMs' unfavorable contracts and low reimbursement rates.
Independent pharmacies in the US are closing at an alarming rate, and the Federal Trade Commission (FTC) has accused pharmacy benefit managers (PBMs) of being a major cause of this problem. PBMs, acting as intermediaries between drug manufacturers and insurance companies, are accused of inflating drug costs and squeezing independent pharmacies through unfavorable contracts and low reimbursement rates, making it more difficult and expensive for independent pharmacies to fill prescriptions.
July 29, 2024
6 Articles